[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [The Biggest "Missing Ingredient" in the $7 Trillion EV Market]( [Don't Miss Your Opportunity to Benefit from This Breaking News]( --------------------------------------------------------------- December 15, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Sponsor Message [Elon Musk and Bill Gates Agree On Nuclear Energy?]( Elon Musk to Bill Gates to politicians on both sides of the aisle, powerful people are now backing the expanded use of nuclear energy. They believe that safe, advanced nuclear technologies will play a vital role in our clean energy transition. Unfortunately, we're far too dependent on Russia for our uranium supply. That's why we desperately need more DOMESTIC sources of the yellow metal that fuels nuclear reactors. [See Why Uranium Should Now Be On Every Investor's Radar]( --------------------------------------------------------------- [Profound Medical, PROF]( Recent Analyst Action: Michael Sarcone, analyst at Jefferies, reiterates coverage on [Profound Medical (PROF)](in the Healthcare sector with a Buy rating and a price target of $5.5 (1 month ago). - Recent Price: $8.985 - Average Analyst Price Target: $8.99 (0.17%) - Market Cap: $186.36M [TipRanks.com]( also reports that [Profound Medical](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $8.99. The target pricing ranges from a high forecast of $14.99 down to a low forecast of $5.50. [Profound Medical (PROF)](’s last closing price was $8.98 which would put the average price target at $9.00. Here are 3rd party ratings for [PROF](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 37% (91 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Snowball Your Nest Egg Returns]( ve been studying two new stocks carefully and they've both been paying dividends every week — regular as clockwork. One’s more aggressive and pays a nickel per share every Friday. The second is expected to yield 3% - 4% in the first year. And it also pays every Thursday. We can use these two new ETFs to pay for our groceries, gas or restaurant bills. Or, reinvest the dividends and quickly snowball our nest eggs to help meet our retirement goals. Today, I want to share this information with you, absolutely free. [Click here for details.]( --------------------------------------------------------------- [Fluence Energy, FLNC]( Recent Analyst Action: Ben Kallo, analyst at Robert W. Baird, reiterates coverage on [Fluence Energy (FLNC)](in the Industrial Goods sector with a Buy rating and a price target of $27.00 (1 day ago). - Recent Price: $21.98 - Average Analyst Price Target: $22.00 (0.09%) - Market Cap: $3.82B [TipRanks.com]( also reports that [Fluence Energy](currently has 6 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $22.00. The target pricing ranges from a high forecast of $27.00 down to a low forecast of $13.00. [Fluence Energy (FLNC)](’s last closing price was $21.98 which would put the average price target at $22.00. Here are 3rd party ratings for [FLNC](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Bottom 32% (168 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- [Rocket Pharmaceuticals, RCKT]( Recent Analyst Action: Yun Zhong, analyst at BTIG, reiterates coverage on [Rocket Pharmaceuticals (RCKT)](in the Healthcare sector with a Buy rating and a price target of $35.00 (2 days ago). - Recent Price: $22.88 - Average Analyst Price Target: $54.56 (138.46%) - Market Cap: $1.79B [TipRanks.com]( also reports that [Rocket Pharmaceuticals](currently has 11 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $54.56. The target pricing ranges from a high forecast of $75.00 down to a low forecast of $33.00. [Rocket Pharmaceuticals (RCKT)](’s last closing price was $22.88 which would put the average price target at $54.56. Here are 3rd party ratings for [RCKT](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 23% (58 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [This "recession proof" trade can generate up to $1,475 per week]( s some good news… you're just in time to collect extra cash using one low-risk trade. This "Recession-proof" trade can generate up to $1,475 per week… in up markets and in down markets or anything in between. And it can happen just days from now. [Get in before it's too late by clicking here.]( This trade can boost your income fast, especially if you're at or near retirement age and need an extra low-risk income stream. [Check out the details here.]( --------------------------------------------------------------- [Biomea Fusion, BMEA]( Recent Analyst Action: Joseph Pantginis, analyst at H.C. Wainwright, reiterates coverage on [Biomea Fusion (BMEA)](in the Healthcare sector with a Buy rating and a price target of $37.00 (10 hours ago). - Recent Price: $7.219 - Average Analyst Price Target: $29.50 (308.64%) - Market Cap: $215.18M [TipRanks.com]( also reports that [Biomea Fusion](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $29.50. The target pricing ranges from a high forecast of $37.00 down to a low forecast of $22.00. [Biomea Fusion (BMEA)](’s last closing price was $7.219 which would put the average price target at $29.50. Here are 3rd party ratings for [BMEA](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 23% (58 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- [Sight Sciences, SGHT]( Recent Analyst Action: Joanne Wuensch, analyst at Citigroup, reiterates coverage on [Sight Sciences (SGHT)](in the Healthcare sector with a Buy rating and a price target of $15.00 (3 days ago). - Recent Price: $14.18 - Average Analyst Price Target: $12.33 (-13.05%) - Market Cap: $671.23M [TipRanks.com]( also reports that [Sight Sciences](currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $12.33. The target pricing ranges from a high forecast of $15.00 down to a low forecast of $11.00. [Sight Sciences (SGHT)](’s last closing price was $14.18 which would put the average price target at $12.33. Here are 3rd party ratings for [SGHT](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 31% (77 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Tech Billionaires Embrace Nuclear-Powered Future]( Musk warns that shutting down nuclear plants is "insane" and a threat to national security. He believes we should be INCREASING nuclear power generation - and he's not alone. Bezos, Thiel, and Gates are also investing heavily in nuclear start-ups. So it's no wonder that investors looking for "the next lithium" are now taking a fresh look at uranium, the yellow metallic fuel that powers nuclear reactors. [See What's Going On Today With Uranium and the Nuclear Sector]( --------------------------------------------------------------- [Horizon Therapeutics, HZNP]( Recent Analyst Action: David Risinger, analyst at SVB Securities, reiterates coverage on [Horizon Therapeutics (HZNP)](in the Healthcare sector with a Hold rating and a price target of $116.5 (2 days ago). - Recent Price: $113.26 - Average Analyst Price Target: $110.41 (-2.52%) - Market Cap: $25.64B [TipRanks.com]( also reports that [Horizon Therapeutics](currently has 12 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $110.41. The target pricing ranges from a high forecast of $140.00 down to a low forecast of $76.00. [Horizon Therapeutics (HZNP)](’s last closing price was $113.26 which would put the average price target at $110.41. Here are 3rd party ratings for [HZNP](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 23% (58 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- [Energy Vault Holdings, NRGV]( Recent Analyst Action: Stephen Gengaro, analyst at Stifel Nicolaus, reiterates coverage on [Energy Vault Holdings (NRGV)](in the Industrial Goods sector with a Buy rating and a price target of $9.00 (3 weeks ago). - Recent Price: $3.15 - Average Analyst Price Target: $6.33 (100.95%) - Market Cap: $425.87M [TipRanks.com]( also reports that [Energy Vault Holdings](currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $6.33. The target pricing ranges from a high forecast of $9.00 down to a low forecast of $3.00. [Energy Vault Holdings (NRGV)](’s last closing price was $3.15 which would put the average price target at $6.33. Here are 3rd party ratings for [NRGV](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Buy, Bottom 32% (168 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Will This Jumpstart a New Uranium Boom Market?]( in the early 2000's, Paladin Energy was the darling of the last uranium boom when it shot up from ten cents to over nine dollars. Today's uranium supply/demand imbalance has a lot in common with the last market cycle. Combined with a strong comeback for nuclear energy, this could be setting the stage for the next uranium boom. [Get the Full Story on Uranium Opportunities Here]( --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software